{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:26Z","timestamp":1759403426235,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005689","name":"G\u00f6teborgs L\u00e4kares\u00e4llskap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.11.034","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T09:18:24Z","timestamp":1574932704000},"page":"1084-1088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Humoral immunity to tetanus, diphtheria and polio in adults after treatment for hematological malignancies"],"prefix":"10.1016","volume":"38","author":[{"given":"Sigrun","family":"Einarsdottir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertil","family":"Kaijser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"Nicklasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Horal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Norder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Brune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2019.11.034_b0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00043426-200411000-00008","article-title":"Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus and Haemophilus influenza type b","volume":"26","author":"Ek","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.11.034_b0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-2007-990290","article-title":"Dipththeria (D) and Tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05\/92","volume":"219","author":"Calaminus","year":"2007","journal-title":"Klin Pediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2019.11.034_b0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/pbc.22135","article-title":"Humoral immunity to diphtheria, tetanus, measles and haemophilus influnenzae type B in children with acute lymphoblastic leukemia and responses to re-vaccination","volume":"53","author":"Zengin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2019.11.034_b0020","first-page":"469","article-title":"Tetanus immunity in patients with hematological malignancies","volume":"6","author":"Hammarstr\u00f6m","year":"1998","journal-title":"Supportive Care Cancer"},{"key":"10.1016\/j.vaccine.2019.11.034_b0025","doi-asserted-by":"crossref","unstructured":"World Health Organisation (2017). Tetanus vaccines: WHO position paper Recommendations (2018). Vaccine, 36(25), 3573\u20133575. doi: 10.1016\/j.vaccine.2017.02.034.","DOI":"10.1016\/j.vaccine.2017.02.034"},{"issue":"2","key":"10.1016\/j.vaccine.2019.11.034_b0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.vaccine.2017.08.024","article-title":"Diphtheria vaccines: WHO position paper, august 2017-recommendations","volume":"36","author":"World Health Organisation","year":"2018","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2019.11.034_b0035","first-page":"145","article-title":"Polio vaccines: WHO position paper \u2013 March, 2016","volume":"91","author":"World Health Organisation","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.11.034_b0040","doi-asserted-by":"crossref","unstructured":"Wagner KS, White JM, Lucenko I, Mercer D, Crowcroft NS, Neal S et al. (2012). Diphtheria surveillance network. Diphtheria in the postepidemic period, Europe, 2000\u20132009. Emerg Infect Dis 18(2), 217\u2013225. doi: 10.3201\/eid1802.110987.","DOI":"10.3201\/eid1802.110987"},{"key":"10.1016\/j.vaccine.2019.11.034_b0045","unstructured":"WHO, World-Health-Organisation <https:\/\/www.who.int\/features\/qa\/07\/en\/>; 2018 [accessed 15 May, 2019]."},{"key":"10.1016\/j.vaccine.2019.11.034_b0050","unstructured":"Folkh\u00e4lsomyndigheten [Public Health Agency of Sweden]. (2007). Vaccinationsuppf\u00f6ljning [Vaccination follow-up]: Seroepidemiologisk tv\u00e4rsnittsstudie [sero-epidemiological cross-sectional study]. 2007. <https:\/\/www.folkhalsomyndigheten.se\/contentassets\/81a1221e506b43ee980a851034b8aefa\/vaccinationsuppfoljning-seroepidemiologisk-tvarsnittsstudie-2007.pdf> [last accessed 15 May 2019]."},{"issue":"5","key":"10.1016\/j.vaccine.2019.11.034_b0055","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/ije\/27.5.916","article-title":"Immunity to tetanus, diphtheria and poliomyelitis in the adult population of Sweden in 1991","volume":"27","author":"B\u00f6ttiger","year":"1998","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.11.034_b0060","unstructured":"Socialstyrelsen [The National Board of Health and Welfare], 2009. Rekommendationer f\u00f6r profylax till vuxna mot stelkramp och difteri. [Recommendations for prophylaxis for adults for tetanus and diphtheria]; 2009 <https:\/\/www.folkhalsomyndigheten.se\/contentassets\/17e8c45c5830413cb67392b783d54e4b\/rekommendationer-for-profylax-till-vuxna-mot-difteri-och-stelkramp-2009-130-5.pdf> [last accessed 15 May 2019]."},{"issue":"26","key":"10.1016\/j.vaccine.2019.11.034_b0065","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1182\/blood-2011-08-372649","article-title":"Rituximab blocks serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within six months after treatment","volume":"118","author":"Yri","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.vaccine.2019.11.034_b0070","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1016\/j.bbmt.2012.11.297","article-title":"Plasma cell CD20 expression: primary aberrant expression or receptor up-regulation","volume":"19","author":"Khaled","year":"2013","journal-title":"Biol Blood Marrow Transplantation"},{"issue":"4","key":"10.1016\/j.vaccine.2019.11.034_b0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/07357900701809068","article-title":"Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma","volume":"26","author":"Walker","year":"2008","journal-title":"Cancer Invest"},{"issue":"6","key":"10.1016\/j.vaccine.2019.11.034_b0080","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/08830185.2017.1346092","article-title":"Risk factors predisposing to the development of hypogammaglobulinemia and infections post-Rituximab","volume":"36","author":"Christou","year":"2017","journal-title":"Int Rev Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:40:43Z","timestamp":1759401643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19315592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19315592"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral immunity to tetanus, diphtheria and polio in adults after treatment for hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}